Sfoglia per Rivista CANCER CHEMOTHERAPY AND PHARMACOLOGY
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma.
2008-01-01 M., Reni; Berardi, Rossana; A., Mambrini; L., Pasetto; S., Cereda; V. D., Ferrari; Cascinu, Stefano; M., Cantore; E., Mazza; S., Grisanti
Etoposide, leucovorin, 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study.
1994-01-01 Cascinu, Stefano; A., Fedeli; G., Catalano
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study.
2012-01-01 A., Zaniboni; E., Aitini; S., Barni; D., Ferrari; Cascinu, Stefano; V., Catalano; G., Valmadre; D., Ferrara; E., Veltri; C., Codignola; R., Labianca
Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients.
2008-01-01 Braconi, C; Bracci, R; Bearzi, I; Bianchi, F; Sabato, S; Mandolesi, A; Belvederesi, L; Cascinu, Stefano; Valeri, N; Cellerino, R.
Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer.
1996-01-01 Cascinu, Stefano; P., Alessandroni; D., Rossi; E. D., Ferro; A., Fedeli; V., Casadei; G., Catalano
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial
2011-01-01 Cascinu, S; Galizia, E; Labianca, R; Ferraù, F; Pucci, F; Silva, Rr; Luppi, G; Beretta, Gd; Berardi, Rossana; Scartozzi, M.
Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma.
2010-01-01 F., Loupakis; G., Masi; L., Fornaro; E., Vasile; G., Allegrini; E., Fontana; C., Granetto; L., Salvatore; L., Mentuccia; M., Andreuccetti; E., Cortesi; M., Merlano; Cascinu, Stefano; A., Falcone
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma. | 1-gen-2008 | M., Reni; Berardi, Rossana; A., Mambrini; L., Pasetto; S., Cereda; V. D., Ferrari; Cascinu, Stefano; M., Cantore; E., Mazza; S., Grisanti | |
| Etoposide, leucovorin, 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study. | 1-gen-1994 | Cascinu, Stefano; A., Fedeli; G., Catalano | |
| FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study. | 1-gen-2012 | A., Zaniboni; E., Aitini; S., Barni; D., Ferrari; Cascinu, Stefano; V., Catalano; G., Valmadre; D., Ferrara; E., Veltri; C., Codignola; R., Labianca | |
| Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients. | 1-gen-2008 | Braconi, C; Bracci, R; Bearzi, I; Bianchi, F; Sabato, S; Mandolesi, A; Belvederesi, L; Cascinu, Stefano; Valeri, N; Cellerino, R. | |
| Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer. | 1-gen-1996 | Cascinu, Stefano; P., Alessandroni; D., Rossi; E. D., Ferro; A., Fedeli; V., Casadei; G., Catalano | |
| Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial | 1-gen-2011 | Cascinu, S; Galizia, E; Labianca, R; Ferraù, F; Pucci, F; Silva, Rr; Luppi, G; Beretta, Gd; Berardi, Rossana; Scartozzi, M. | |
| Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma. | 1-gen-2010 | F., Loupakis; G., Masi; L., Fornaro; E., Vasile; G., Allegrini; E., Fontana; C., Granetto; L., Salvatore; L., Mentuccia; M., Andreuccetti; E., Cortesi; M., Merlano; Cascinu, Stefano; A., Falcone |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile